600420 Shanghai Shyndec Pharmaceutical
- 11.65
- +0.06+0.52%
Shanghai Shyndec Pharmaceutical News
Voluntary information disclosure announcement regarding the consistency evaluation of pharmaceuticals through generic drugs.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
2023 Annual General Meeting of Shareholders Legal Opinions
Independent director system
Notice on termination of the cooperation framework agreement at the end of the term
Progress announcement on the signing of the “Drug Marketing License Transfer Contract” by the holding subsidiary
Notice on wholly-owned subsidiaries obtaining drug registration certificates
2023 Annual General Meeting of Shareholders Meeting Materials
Announcement on holding the results briefing for the first quarter of 2023 and 2024
Announcement on the acquisition of CEP certification for APIs from Wholly-owned Sun Company
Notice on convening the 2023 Annual General Meeting of Shareholders
Announcement of Resolutions of the 13th Meeting of the Eighth Board of Directors
Announcement of Resolutions of the Eighth Meeting of the Eighth Board of Supervisors
2024 First Quarter Report
Investor Relations Activity Record Form
Voluntary Information Disclosure Notice on Wholly Owned Subsidiary Drugs Passing the Generic Drug Consistency Evaluation
Notice on wholly-owned subsidiaries obtaining drug registration certificates
Voluntary Disclosure Notice for the First Quarter of 2024 Earnings Forecast
CITIC Securities Co., Ltd.'s 2023 Continued Supervision Report on Shanghai Modern Pharmaceutical Co., Ltd.
Announcement on the holding subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Analysis
Price Target
No Data
